Published in Lancet on November 24, 1990
Epilepsy in a population of 6000 re-examined: secular trends in first attendance rates, prevalence, and prognosis. J Neurol Neurosurg Psychiatry (1995) 2.84
Epidemiology of the epilepsies. J Neurol Neurosurg Psychiatry (1996) 2.62
A general practice records audit of the process of care for people with epilepsy. Br J Gen Pract (1996) 1.53
The natural history of epilepsy: an epidemiological view. J Neurol Neurosurg Psychiatry (2004) 1.51
National general practice study of epilepsy: the social and psychological effects of a recent diagnosis of epilepsy. BMJ (1992) 1.45
Epilepsy surgery outcomes in temporal lobe epilepsy with a normal MRI. Epilepsia (2009) 1.41
Care of patients with epilepsy in the community: will new initiatives address old problems? Br J Gen Pract (1996) 1.28
Epilepsy. J Neurol Neurosurg Psychiatry (1994) 1.16
Management of refractory complex partial seizures: current state of the art. Neuropsychiatr Dis Treat (2010) 1.14
The characteristics of epilepsy in a largely untreated population in rural Ecuador. J Neurol Neurosurg Psychiatry (1994) 1.03
Single Unprovoked Seizures. Curr Treat Options Neurol (2004) 0.98
Epilepsy care: a need for change. Br J Gen Pract (1994) 0.95
High resolution magnetic resonance imaging in adults with partial or secondary generalised epilepsy attending a tertiary referral unit. J Neurol Neurosurg Psychiatry (1995) 0.93
Clinical application of neuroimaging in epilepsy. J Neurol Neurosurg Psychiatry (2003) 0.92
Temporal lobe epilepsy surgery failures: a review. Epilepsy Res Treat (2012) 0.92
Impact of antiepileptic drugs on bone health: Need for monitoring, treatment, and prevention strategies. J Family Med Prim Care (2016) 0.92
The neuropathology of obesity: insights from human disease. Acta Neuropathol (2013) 0.91
Incidence of convulsive epilepsy in a rural area in Kenya. Epilepsia (2013) 0.88
Sudden unexpected death in epilepsy. Postgrad Med J (1999) 0.84
How to avoid a misdiagnosis in patients presenting with transient loss of consciousness. Postgrad Med J (2006) 0.82
Clinical course of poststroke epilepsy: a retrospective nested case-control study. Brain Behav (2015) 0.81
Naturally occurring carboxypeptidase A6 mutations: effect on enzyme function and association with epilepsy. J Biol Chem (2012) 0.81
Difficulties in Treatment and Management of Epilepsy and Challenges in New Drug Development. Pharmaceuticals (Basel) (2010) 0.80
Seizure characteristics in multiple sclerosis patients. J Res Med Sci (2013) 0.79
The adolescent or adult with generalized tonic-clonic seizures. Ann Indian Acad Neurol (2012) 0.78
Does treatment with t-PA increase the risk of developing epilepsy after stroke? J Neurol (2015) 0.77
Computed tomography in first uncomplicated generalised seizure. Is grossly oversold. BMJ (1995) 0.76
Safety, efficacy, and life satisfaction following epilepsy surgery in patients aged 60 years and older. J Neurosurg (2015) 0.75
Newly diagnosed seizures in adolescents: a comparative study. J Family Community Med (2003) 0.75
Epilepsy in the elderly: Special considerations and challenges. Ann Indian Acad Neurol (2014) 0.75
Psychosocial factors in chronicity of epilepsy. J Neurol Neurosurg Psychiatry (1995) 0.75
Diagnostic outcome of surgical revision of intracranial electrode placements for seizure localization. J Clin Neurophysiol (2014) 0.75
Neuroimaging observations in a cohort of elderly manifesting with new onset seizures: Experience from a university hospital. Ann Indian Acad Neurol (2012) 0.75
Health care cost associated with the use of enzyme-inducing and non-enzyme-active antiepileptic drugs in the UK: a long-term retrospective matched cohort study. BMC Neurol (2017) 0.75
Incidence of epilepsy is now higher in elderly people than children. BMJ (1998) 0.75
Incidence of epilepsy in Ferrara, Italy. Neurol Sci (2013) 0.75
Comparison of adaptive pacing therapy, cognitive behaviour therapy, graded exercise therapy, and specialist medical care for chronic fatigue syndrome (PACE): a randomised trial. Lancet (2011) 10.73
Increased absenteeism from work after detection and labeling of hypertensive patients. N Engl J Med (1978) 9.29
Randomised clinical trial of strategies for improving medication compliance in primary hypertension. Lancet (1975) 7.22
One drug for epilepsy. Br Med J (1978) 4.87
Improvement of medication compliance in uncontrolled hypertension. Lancet (1976) 4.84
The incidence and lifetime prevalence of neurological disorders in a prospective community-based study in the UK. Brain (2000) 4.76
Anomalous origin of the left coronary artery from the pulmonary trunk. Its clinical spectrum, pathology, and pathophysiology, based on a review of 140 cases with seven further cases. Circulation (1968) 4.34
Mortality from epilepsy: results from a prospective population-based study. Lancet (1994) 4.31
Control of DNA synthesis genes in fission yeast by the cell-cycle gene cdc10+. Nature (1992) 4.13
Hippocampal sclerosis in epilepsy and childhood febrile seizures. Lancet (1993) 3.71
Pathway correcting DNA replication errors in Saccharomyces cerevisiae. EMBO J (1993) 3.57
Reduction in polypharmacy for epilepsy. Br Med J (1979) 3.56
Coordination of expression of DNA synthesis genes in budding yeast by a cell-cycle regulated trans factor. Nature (1991) 3.53
Coordinated regulation of gene expression by the cell cycle transcription factor Swi4 and the protein kinase C MAP kinase pathway for yeast cell integrity. EMBO J (1996) 3.45
A multicopy suppressor gene of the Saccharomyces cerevisiae G1 cell cycle mutant gene dbf4 encodes a protein kinase and is identified as CDC5. Mol Cell Biol (1993) 3.33
SWI6 protein is required for transcription of the periodically expressed DNA synthesis genes in budding yeast. Nature (1992) 3.32
Vigabatrin and behaviour disturbances. Lancet (1990) 3.30
Monotherapy or polytherapy for epilepsy? Epilepsia (1981) 3.25
Remission of epilepsy: results from the National General Practice Study of Epilepsy. Lancet (1995) 3.17
Unnecessary polypharmacy for epilepsy. Br Med J (1977) 3.12
Epileptic seizures in a population of 6000. I: Demography, diagnosis and classification, and role of the hospital services. Br Med J (Clin Res Ed) (1983) 2.95
Epilepsy in a population of 6000 re-examined: secular trends in first attendance rates, prevalence, and prognosis. J Neurol Neurosurg Psychiatry (1995) 2.84
Recovery from chronic fatigue syndrome after treatments given in the PACE trial. Psychol Med (2013) 2.82
Drowning in people with epilepsy: how great is the risk? Neurology (2008) 2.80
P40SDB25, a putative CDK inhibitor, has a role in the M/G1 transition in Saccharomyces cerevisiae. Genes Dev (1994) 2.72
National General Practice Study of Epilepsy: recurrence after a first seizure. Lancet (1990) 2.65
Epidemiology of the epilepsies. J Neurol Neurosurg Psychiatry (1996) 2.62
Randomised controlled trial to assess acceptability of phenobarbital for childhood epilepsy in rural India. Lancet (1998) 2.58
DNA polymerase II, the probable homolog of mammalian DNA polymerase epsilon, replicates chromosomal DNA in the yeast Saccharomyces cerevisiae. EMBO J (1992) 2.51
Falls in the elderly related to postural imbalance. Br Med J (1977) 2.47
The yeast DNA polymerase I transcript is regulated in both the mitotic cell cycle and in meiosis and is also induced after DNA damage. Nucleic Acids Res (1987) 2.38
Comprehensive primary health care antiepileptic drug treatment programme in rural and semi-urban Kenya. ICBERG (International Community-based Epilepsy Research Group) Lancet (1991) 2.36
Infection of the uterine cervix with Chlamydia trachomatis. J Infect Dis (1978) 2.36
Cloning DPB3, the gene encoding the third subunit of DNA polymerase II of Saccharomyces cerevisiae. Nucleic Acids Res (1991) 2.34
Early prognosis of epilepsy. Br Med J (Clin Res Ed) (1982) 2.30
Hippocampal volumetric and morphometric studies in frontal and temporal lobe epilepsy. Brain (1992) 2.29
Incidence and prevalence studies in epilepsy and their methodological problems: a review. J Neurol Neurosurg Psychiatry (1987) 2.25
Identification of angiotensin II receptor subtypes. Biochem Biophys Res Commun (1989) 2.23
Surgical outcome in patients with epilepsy and dual pathology. Brain (1999) 2.19
Prevention of relapse in residual depression by cognitive therapy: a controlled trial. Arch Gen Psychiatry (1999) 2.12
The intensive care treatment of convulsive status epilepticus in the UK. Results of a national survey and recommendations. Anaesthesia (1995) 2.12
Is cardiac resuscitation worthwhile? A decade of experience. N Engl J Med (1972) 2.07
PAX6 haploinsufficiency causes cerebral malformation and olfactory dysfunction in humans. Nat Genet (2001) 2.05
Aetiology of urinary symptoms in sexually active women. Genitourin Med (1986) 2.03
Integrated hospital and community psychiatric services and use of inpatient beds. BMJ (1989) 2.03
Epileptic seizures in a population of 6000. II: Treatment and prognosis. Br Med J (Clin Res Ed) (1983) 1.98
The forkhead protein Fkh2 is a component of the yeast cell cycle transcription factor SFF. EMBO J (2000) 1.95
Validation of a screening questionnaire for the detection of epileptic seizures in epidemiological studies. Brain (1992) 1.94
Apnoea and bradycardia during epileptic seizures: relation to sudden death in epilepsy. J Neurol Neurosurg Psychiatry (1996) 1.89
Cranial cruciate ligament rupture. Pathogenesis, diagnosis, and postoperative rehabilitation. Vet Clin North Am Small Anim Pract (1993) 1.89
Results of cardiac resuscitation in 552 patients. Am J Cardiol (1967) 1.88
The temporal aspects of prognosis in epilepsy. J Neurol Neurosurg Psychiatry (1984) 1.85
Expression of the yeast DNA primase gene, PRI1, is regulated within the mitotic cell cycle and in meiosis. Mol Gen Genet (1990) 1.85
Expanded profile of the SHAFT syndrome. J Hand Surg Am (1998) 1.84
Overlapping and distinct roles of the duplicated yeast transcription factors Ace2p and Swi5p. Mol Microbiol (2001) 1.82
Order of function of the budding-yeast mitotic exit-network proteins Tem1, Cdc15, Mob1, Dbf2, and Cdc5. Curr Biol (2001) 1.76
Oral contraceptives, depression, and libido. Br Med J (1971) 1.74
Association of hippocampal sclerosis with cortical dysgenesis in patients with epilepsy. Neurology (1994) 1.74
Why does epilepsy become intractable? Prevention of chronic epilepsy. Lancet (1983) 1.72
The Skn7 response regulator of Saccharomyces cerevisiae interacts with Hsf1 in vivo and is required for the induction of heat shock genes by oxidative stress. Mol Biol Cell (2000) 1.69
Mortality in patients with epilepsy: a study of patients in long term residential care. J Neurol Neurosurg Psychiatry (1993) 1.64
Methods for normalization of hippocampal volumes measured with MR. AJNR Am J Neuroradiol (1995) 1.64
A post-mortem study of the cholinergic and GABA systems in senile dementia. Brain (1982) 1.62
Involvement of apoptosis in ovarian follicular atresia and postovulatory regression. Endocrinology (1991) 1.61
Nonpeptide angiotensin II receptor antagonists. XI. Pharmacology of EXP3174: an active metabolite of DuP 753, an orally active antihypertensive agent. J Pharmacol Exp Ther (1990) 1.60
A Bub2p-dependent spindle checkpoint pathway regulates the Dbf2p kinase in budding yeast. EMBO J (1999) 1.60
The Swi5 transcription factor of Saccharomyces cerevisiae has a role in exit from mitosis through induction of the cdk-inhibitor Sic1 in telophase. Genetics (1997) 1.59
Duration of relapse prevention after cognitive therapy in residual depression: follow-up of controlled trial. Psychol Med (2005) 1.59
Presurgical evaluation of patients with epilepsy and normal MRI: role of scalp video-EEG telemetry. J Neurol Neurosurg Psychiatry (1999) 1.59
Incidence of sudden unexpected death in an adult outpatient cohort with epilepsy at a tertiary referral centre. J Neurol Neurosurg Psychiatry (1995) 1.58
A longitudinal study of brain morphometrics using quantitative magnetic resonance imaging and difference image analysis. Neuroimage (2003) 1.58
Nonpeptide angiotensin II receptor antagonists. VII. Cellular and biochemical pharmacology of DuP 753, an orally active antihypertensive agent. J Pharmacol Exp Ther (1990) 1.57
Rme1, a negative regulator of meiosis, is also a positive activator of G1 cyclin gene expression. EMBO J (1995) 1.56
The neuropsychiatry of megaloblastic anaemia. Br Med J (1980) 1.56
Mortality in epilepsy in the first 11 to 14 years after diagnosis: multivariate analysis of a long-term, prospective, population-based cohort. Ann Neurol (2001) 1.56
The Nottingham study of neurotic disorder: comparison of drug and psychological treatments. Lancet (1988) 1.53
Depressive symptoms and oral contraceptives. Br Med J (1970) 1.53
Association of the cell cycle transcription factor Mbp1 with the Skn7 response regulator in budding yeast. Mol Biol Cell (1999) 1.53
Nonpeptide angiotensin II receptor antagonists: the discovery of a series of N-(biphenylylmethyl)imidazoles as potent, orally active antihypertensives. J Med Chem (1991) 1.50
Evaluation of vigabatrin as an add-on drug in the management of severe epilepsy. J Neurol Neurosurg Psychiatry (1990) 1.48
Cognition and survival: an exploration in a large multicentre study of the population aged 65 years and over. Int J Epidemiol (2001) 1.48
Evaluation of fibular head transposition, lateral fabellar suture, and conservative treatment of cranial cruciate ligament rupture in large dogs: a retrospective study. J Am Anim Hosp Assoc (1996) 1.48
Is nocturnal paroxysmal dystonia a form of frontal lobe epilepsy? Mov Disord (1992) 1.47
Self-recording of blood pressure in the management of hypertension. Can Med Assoc J (1978) 1.46
Nonpeptide angiotensin II receptor antagonists. VIII. Characterization of functional antagonism displayed by DuP 753, an orally active antihypertensive agent. J Pharmacol Exp Ther (1990) 1.46
The prognosis for seizure control in newly diagnosed epilepsy. N Engl J Med (1984) 1.46
National general practice study of epilepsy: the social and psychological effects of a recent diagnosis of epilepsy. BMJ (1992) 1.45
A new class of synthetic auxin transport inhibitors. Plant Physiol (1976) 1.45
The cost of epilepsy in the United Kingdom: an estimation based on the results of two population-based studies. Epilepsy Res (1994) 1.44
Randomised comparative monotherapy trial of phenobarbitone, phenytoin, carbamazepine, or sodium valproate for newly diagnosed childhood epilepsy. Lancet (1996) 1.41